Effectiveness of BNT162b2 Vaccine against Delta Variant in Adolescents

  • Reis B
  • Barda N
  • Leshchinsky M
  • et al.
87Citations
Citations of this article
91Readers
Mendeley users who have this article in their library.

Abstract

The studies on infectiousness of person infected with SARS-CoV-2 at different stages of illness are an important basis for making effective prevention and control measures such as investigating the infectious source, determining the scope of close contacts and the timing of case isolation. This review discusses the infectiousness of cases infected with SARS-CoV-2 in the incubation period, symptomatic period and convalescent period by reviewing national and international literatures, technical and professional guidelines. Existing researches suggest that the infectious viruses could be isolated at the end of the incubation period as well as since illness onset, and viral load in upper respiratory tract swabs reached the peak on day 4-6 after illness onset and thereafter began to decline, implying the infectiousness was relatively strong at the end of incubation period and within one week after illness onset. Although there were a few cases who tested positive for SARS-CoV-2 after recovery, no evidence was found to indicate these cases can cause the transmission.

Cite

CITATION STYLE

APA

Reis, B. Y., Barda, N., Leshchinsky, M., Kepten, E., Hernán, M. A., Lipsitch, M., … Balicer, R. D. (2021). Effectiveness of BNT162b2 Vaccine against Delta Variant in Adolescents. New England Journal of Medicine, 385(22), 2101–2103. https://doi.org/10.1056/nejmc2114290

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free